OXYMYCINE LA Solution

国家: 加拿大

语言: 法文

来源: Health Canada

有效成分:

Oxytétracycline (Dihydrate d'oxytétracycline)

可用日期:

ZOETIS CANADA INC

剂量:

200MG

药物剂型:

Solution

组成:

Oxytétracycline (Dihydrate d'oxytétracycline) 200MG

给药途径:

Intramusculaire

每包单位数:

250ML/500ML

处方类型:

Prescription

治疗组:

Bétails; Porcs

產品總結:

Numéro de groupe d'ingrédients actifs (GIA) :0105553001

授权状态:

APPROUVÉ

授权日期:

2012-03-02

资料单张

PROOF Nº
COMPONENT
PHARMA CODE
PAR
DESCRIPTION
MARKET
SUPPLIER
SUPPLIER Nº
PERIGORD Nº
COLOURS
Canada
Norbrook
OXYTETRACYCLINE DIHY SSOL 200 MG 500 ML GBTL 1 EA MULT
PAR-2014-0021629
03
Extended Content Label
1279
BLACK
PROFILE
13:53
TIME:
12 AUG 2014
DATE:
TEXT SIZE
4.2 PT
THE BODY TEXT
ON THIS A/W IS AT:
003030L07
233001
DIMENSIONS
58 x 202 mm
DRAWING NUMBER
N/A
PMS 1805
003030L07
2653-09-0
1279
1279
003030L07
2653-09-0
1279
LOT
EXP.
PEEL HERE / DÉTACHEZ ICI.
DESCRIPTION:
Oxymycine LA Injectable Solution is specially formulated to provide
sustained antibiotic
blood levels up to 4 days in cattle and pigs following a single
treatment.
Oxymycine LA is a sterile, long acting stable aqueous solution
containing oxytetracycline
dihydrate equivalent to 200 mg oxytetracycline base per mL.
INDICATIONS:
Oxymycine LA Injectable Solution is indicated in the treatment of
infections caused by
oxytetracycline susceptible bacteria in cattle and swine.
DOSAGE AND ADMINISTRATION:
_To reduce the development of antimicrobial resistance and maintain
effectiveness, use this_
_antibiotic prudently._
For administration by intramuscular injection to cattle and swine and
subcutaneous injection
to cattle only.
Cattle: administer by deep intramuscular injection or subcutaneous
injection at a single
dose rate of 1 mL per 10 kg of live bodyweight (20 mg oxytetracycline
per kg bodyweight).
Swine: administer by deep intramuscular injection at a single dose
rate of 1 mL per 10 kg of
live bodyweight (20 mg oxytetracycline per kg bodyweight).
It is recommended that the maximum dose at any one site is 10 mL in
cattle and 5 mL in
pigs in order to minimise local tissue irritation at the injection
site. Intramuscular injections
should be made deep into the fleshy part of the muscle such as the
thigh or neck region.
Following administration, temporary localised swelling may be observed
at the site of
injection for several days. This is due to the high concentration and
long acting effect of the
product.
Oxymycine LA Injectable Solution should be w